GLOBAL CLINICAL NUTRITION MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • GLOBAL CLINICAL NUTRITION MARKET FORECAST 2019-2028

GLOBAL CLINICAL NUTRITION MARKET FORECAST 2019-2028

The global clinical nutrition market is projected to register a CAGR of 5.11% between 2019 and 2028, and is anticipated to generate revenue of $47765 million by 2028. Clinical nutrition diagnoses and treats diseases that affect the intake, intestinal absorption, and metabolism of constituents of the diet, and help promote health through the prevention of diet-related diseases.

GLOBAL CLINICAL NUTRITION MARKET FORECAST 2019-2028

Global Clinical Nutrition Market by Route of Administration (Oral, Enteral, Parenteral) by Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, Other Applications) by End-user (Pediatric, Geriatric, Adults) and by Geography.

Request free sample

The global clinical nutrition market is projected to register a CAGR of 5.11% between 2019 and 2028, and is anticipated to generate revenue of $47765 million by 2028.

Clinical nutrition diagnoses and treats diseases that affect the intake, intestinal absorption, and metabolism of constituents of the diet, and help promote health through the prevention of diet-related diseases.
global-clinical-nutrition-market

To know more about this report, request a free sample copy

Key factors propelling the global clinical nutrition market growth is:

  • Increasing prevalence of chronic diseases and lifestyle associated disease
    • According to the American Society of parenteral and enteral nutrition, in the U.S., every year, around 150,000 infants and hospitalized patients receive nutrition support modality annually.
    • There is an increase in the number of people suffering from chronic health diseases, such as cancer and diabetes, across the world. The global burden of cancer is estimated to have increased to 18.1 million new cases, with 9.6 million deaths in 2018.
  • Rise in the elderly population
  • High occurrence of malnutrition among hospitalized patients
  • Surging demand in developing economies

Major restraining factors:

  • Lack of awareness for clinical nutrition
  • Complications associated with enteral feeding
    • The complications associated with enteral feeding can be classified majorly into GI, mechanical, metabolic, and infectious complications.
    • GI complications are the most common ones associated with enteral feeding. These complications are seen in 30-40% of all patients using enteral feeding.
  • Stringent regulations

The report scope of the global clinical nutrition market includes the segmentation analysis of route of administration, application, and end-user. These segments are further classified to provide a detailed analysis of the studied market.

Market by Application:

  • Cancer
    • Cancer is both the leading and dominating application.
    • Anorexia and cachexia are common causes of malnutrition in cancer patients. Further, nutritional deficiency is a common medical problem that affects around 15–40% of cancer patients.
  • Neurological Diseases
  • Gastrointestinal disorders
  • Metabolic Disorders
  • Other Applications

Geographically, the global clinical nutrition market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America dominated the global market in 2019. The U.S. dominates the North American market. In addition, due to an increase in the number of people suffering from chronic conditions, such as cancer and diabetes, coupled with a rise in geriatric population, are also anticipated to boost the market growth.
    • As per the National Center for Chronic Disease Prevention and Health Promotion, 2019, chronic ailments such as cancer, heart disease, and diabetes are the chief causes of disability and death in the United States. They are also principal drivers of the nation’s $3.5 trillion in annual health care costs.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia Pacific: India, Australia & New Zealand, China, South Korea, Japan, Thailand, Indonesia, Vietnam, and Rest of Asia Pacific
    • The Asia Pacific is evaluated to be the leading region by 2028. The major factors contributing to the growth of the global clinical nutrition market in the APAC region includes an increased prevalence of metabolic disorders, a rise in geriatric population, and rising expenditure on healthcare.
    • As per UNFPA, by 2050, 1 in 4 people in the Asia Pacific will be over 60 years. The older persons (aged over 60) in the region will triple between 2010 and 2050.
  • Rest of World: Latin America, the Middle East & Africa

The major market players in the global clinical nutrition market are:

  • Abbott laboratories
  • BASF SE
  • Braun
  • Lonza Ltd
  • Sanofi
  • Others

Key strategies adopted by some of the clinical nutrition companies:

In February 2020, Baxter International Inc announced the U.S. Food and Drug Administration clearance of Q-NRG+, which is a metabolic nursing device using indirect calorimetry technology. Indirect calorimetry is considered the ‘gold standard’ to precisely measure a patient’s calorie requirements, or resting energy expenditure. These analyses can help notify administration and prescription of nutrition therapy, which may comprise parenteral nutrition, i.e., the administration of nutrients intravenously.

Key findings of the global clinical nutrition market:

  • The oral route is the prominent route of administration.
  • Cancer is the highest revenue-generating application.
  • Pediatric is the fastest-growing end-user.`

Frequently Asked Questions & Answers (FAQ):

  • What is the revenue generated by the North American Market?

         A: As of 2019, North America generated a revenue of $11767 million.

  • What are the key insights of the market report?

         A: One of the key insights is the rising usage of Whey protein in clinical applications.

  • What is the intensity of competition with regard to clinical products?

         A: With a moderate number of substitutes and increased chances of new entrants, the competition in the market is evaluated to be intense, mainly among the probiotic brands

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • INCREASING PREVALENCE OF CHRONIC DISEASES AND LIFESTYLE ASSOCIATED DISEASE
      • RISE IN ELDERLY POPULATION
      • HIGH OCCURRENCE OF MALNUTRITION AMONG HOSPITALIZED PATIENTS
      • SURGING DEMAND IN DEVELOPING ECONOMIES
    •    KEY RESTRAINTS
      • LACK OF AWARENESS FOR CLINICAL NUTRITION
      • COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING
      • STRINGENT REGULATIONS
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY ROUTE OF ADMINISTRATION
    • ORAL
    • ENTERAL
    • PARENTERAL
  3. MARKET BY APPLICATION
    • CANCER
    • NEUROLOGICAL DISEASES
    • GASTROINTESTINAL DISORDERS
    • METABOLIC DISORDERS
    • OTHER APPLICATIONS
  4. MARKET BY END-USER
    • PEDIATRIC
    • GERIATRIC
    • ADULTS
  5. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    •    EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
    •    ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA & NEW ZEALAND
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
    •    REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPANY PROFILES
    • ABBOTT LABORATORIES
    • AMERICAN REGENT INC
    • BASF SE
    • BAXTER INTERNATIONAL INC
    • BRAUN
    • DANONE
    • EXELA PHARMA SCIENCES
    • GRIFOLS SA
    • LONZA LTD
    • MEIJI HOLDINGS CO LTD
    • NESTLE HEALTH SCIENCE
    • OTSUKA HOLDINGS CO LTD
    • RECKITT BENCKISER GROUP PLC
    • SANOFI
    • SICHUAN KELUN PHARMACEUTICAL CO LTD

TABLE LIST

TABLE 1: MARKET SNAPSHOT – CLINICAL NUTRITION

TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION, 2019 AND 2050

TABLE 3: GLOBAL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 4: GLOBAL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 5: GLOBAL ORAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 6: GLOBAL ORAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 7: GLOBAL ENTERAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 8: GLOBAL ENTERAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 9: GLOBAL PARENTERAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 10: GLOBAL PARENTERAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 11: GLOBAL CLINICAL NUTRITION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 12: GLOBAL CLINICAL NUTRITION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 13: GLOBAL CANCER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 14: GLOBAL CANCER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 15: GLOBAL NEUROLOGICAL DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 16: GLOBAL NEUROLOGICAL DISEASES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 17: GLOBAL GASTROINTESTINAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 18: GLOBAL GASTROINTESTINAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 19: GLOBAL METABOLIC DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 20: GLOBAL METABOLIC DISORDERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 21: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 22: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 23: GLOBAL CLINICAL NUTRITION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 24: GLOBAL CLINICAL NUTRITION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 25: GLOBAL PEDIATRIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 26: GLOBAL PEDIATRIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 27: GLOBAL GERIATRIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 28: GLOBAL GERIATRIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 29: GLOBAL ADULTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 30: GLOBAL ADULTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 31: GLOBAL CLINICAL NUTRITION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 32: GLOBAL CLINICAL NUTRITION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 33: NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 34: NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 35: EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 36: EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 37: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 38: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 39: REST OF WORLD CLINICAL NUTRITION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 40: REST OF WORLD CLINICAL NUTRITION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

FIGURE LIST          

FIGURE 1: MAJOR CATEGORIES OF GLOBAL HEALTH SPENDING, 2017

FIGURE 2: COMPLICATIONS OF ENTERAL FEEDING

FIGURE 3: PORTER’S FIVE FORCE ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: KEY INVESTMENT INSIGHTS

FIGURE 7: GLOBAL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, IN 2019

FIGURE 8: GLOBAL CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)

FIGURE 9: GLOBAL CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)

FIGURE 10: GLOBAL CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)

FIGURE 11: GLOBAL CLINICAL NUTRITION MARKET, BY APPLICATION, IN 2019

FIGURE 12: GLOBAL CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)

FIGURE 13: GLOBAL CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)

FIGURE 14: GLOBAL CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)

FIGURE 15: GLOBAL CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)

FIGURE 16: TOP 10 COUNTRIES OR TERRITORIES FOR NUMBER OF PEOPLE WITH DIABETES (20–79 YEARS) IN 2019 (MILLION)

FIGURE 17: GLOBAL CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)

FIGURE 18: GLOBAL CLINICAL NUTRITION MARKET, BY END-USER, IN 2019

FIGURE 19: GLOBAL CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)

FIGURE 20: GLOBAL CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)

FIGURE 21: GLOBAL CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)

FIGURE 22: NORTH AMERICA CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 23: THE UNITED STATES CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 24: CANADA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 25: EUROPE CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 26: GERMANY CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 27: FRANCE CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 28: THE UNITED KINGDOM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 29: ITALY CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 30: RUSSIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 31: BELGIUM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 32: POLAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 33: REST OF EUROPE CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 34: ASIA PACIFIC CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 35: JAPAN CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 36: CHINA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 37: INDIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 38: AUSTRALIA & NEW ZEALAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 39: SOUTH KOREA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 40: THAILAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 41: INDONESIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 42: VIETNAM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 43: REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 44: REST OF WORLD CLINICAL NUTRITION MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 45: LATIN AMERICA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 46: MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

  1. MARKET BY ROUTE OF ADMINISTRATION
    • ORAL
    • ENTERAL
    • PARENTERAL
  2. MARKET BY APPLICATION
    • CANCER
    • NEUROLOGICAL DISEASES
    • GASTROINTESTINAL DISORDERS
    • METABOLIC DISORDERS
    • OTHER APPLICATIONS
  3. MARKET BY END-USER
    • PEDIATRIC
    • GERIATRIC
    • ADULTS
  4. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    •    EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
    •    ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA & NEW ZEALAND
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
    •    REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now